AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing
Pharma company will invest money over five years in ‘strategic partnership’ after ditching UK expansionBusiness live – latest updatesAstraZeneca will invest $2.5bn (£1.9bn) in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and the detention of top executives in China.The investment will be staggered over the next five years as part of a “strategic partnership” with the city’s authorities and includes agreements with three local biotech companies. Continue reading...
Pharma company will invest money over five years in ‘strategic partnership’ after ditching UK expansion
AstraZeneca will invest $2.5bn (£1.9bn) in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and the detention of top executives in China.
The investment will be staggered over the next five years as part of a “strategic partnership” with the city’s authorities and includes agreements with three local biotech companies. Continue reading...
